Targeting tumor-associated macrophages in anti-cancer therapies: convincing the traitors to do the right thing

HIGHLIGHTS

• who: Cristina Belgiovine et al. from the Department of Biomedical Science, Humanitas University, Via Rita Levi Montalcini, Pieve Emanuele, Universidade de Santiago de Compostela, Campus Vida, Santiago de Compostela, Spain have published the Article: Targeting Tumor-Associated Macrophages in Anti-Cancer Therapies: Convincing the Traitors to Do the Right Thing, in the Journal: (JOURNAL)

SUMMARY

Macrophages are specialized phagocytic cells of the innate immune system. In this broad spectrum of activation states, two polarized extremes have been defined: the M1 (or classically activated, pro-inflammatory/anti-tumoral) macrophages and the M2 (or alternatively . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.